# GLRX

## Overview
The GLRX gene encodes the protein glutaredoxin, a small redox enzyme that is integral to maintaining cellular redox homeostasis. Glutaredoxin belongs to the thioredoxin fold superfamily and is characterized by its oxidoreductase activity, which is facilitated by a conserved active site motif, typically CXXC or CXXS (Berndt2021Glutaredoxins). This protein plays a pivotal role in the reversible reduction of disulfide bonds in proteins, a process known as deglutathionylation, which is crucial for regulating various cellular processes, including signal transduction and protection against oxidative stress (Burns2020Role). Glutaredoxin is found in multiple cellular compartments, such as the cytosol and mitochondria, and is involved in diverse functions, including redox signaling and iron-sulfur cluster biosynthesis (Sagemark2007Redox). The GLRX gene's expression and the activity of its encoded protein have significant implications in various diseases, including liver disorders, gliomas, and cardiovascular diseases, making it a potential target for therapeutic interventions (Chang2020Redox; Ahmad2019Processed; Burns2020Role).

## Structure
The human GLRX protein, also known as glutaredoxin, is a small redox enzyme that plays a crucial role in cellular redox homeostasis. Its primary structure features a conserved active site motif, typically CXXC or CXXS, which is essential for its oxidoreductase activity (Berndt2021Glutaredoxins). The secondary structure of GLRX includes a central four-stranded anti-parallel β-sheet surrounded by three α-helices, forming a βαβαββα topology, which is characteristic of the thioredoxin fold superfamily (Berndt2021Glutaredoxins).

The tertiary structure of GLRX is defined by this thioredoxin fold, a common motif in redox proteins, which facilitates its function in reducing oxidized thiols and catalyzing protein glutathionylation (Berndt2021Glutaredoxins). GLRX proteins can undergo post-translational modifications, such as phosphorylation, which may influence their activity and interactions (Berndt2021Glutaredoxins).

GLRX exists in different isoforms due to alternative splicing, allowing it to be targeted to various cellular compartments, including the cytosol and mitochondria (Sagemark2007Redox). These isoforms enable GLRX to participate in diverse cellular processes, including redox signaling and iron-sulfur cluster biosynthesis (Berndt2021Glutaredoxins).

## Function
Glutaredoxin-1 (GLRX) is a crucial enzyme in maintaining cellular redox homeostasis by catalyzing the reversible reduction of disulfide bonds in proteins through a process known as deglutathionylation. This activity is essential for regulating the structure, function, and activity of many proteins involved in cell proliferation, cell death, and metabolism (Burns2020Role). GLRX is primarily localized in the cytosol but is also found in the intermembrane space of mitochondria and potentially in the nucleus, where it plays a role in maintaining mitochondrial function and complex I activity (Mieyal2008Molecular).

In healthy human cells, GLRX helps maintain the balance of redox signaling, which is vital for normal cellular function. It regulates various cellular processes, including signal transduction pathways involving phosphatases, kinases, and transcription factors (Burns2020Role). GLRX also plays a role in protecting cells from oxidative stress by preventing irreversible oxidation of protein thiols during oxidative stress (Burns2020Role). Additionally, GLRX is involved in the modulation of protein S-glutathionylation, affecting proteins like sirtuin-1 (SirT1), which is a central metabolic regulator (Matsui2020Redox). This modulation is crucial for maintaining normal cellular functions and protecting against diseases such as non-alcoholic steatohepatitis (NASH) and atherosclerosis (Matsui2020Redox).

## Clinical Significance
Alterations in the expression of the GLRX gene, which encodes glutaredoxin, have been implicated in various diseases. In the context of liver disorders, particularly nonalcoholic fatty liver disease (NAFLD), GLRX deficiency is associated with increased oxidative stress, leading to hepatic lipid accumulation and inflammation. This condition is exacerbated by diets high in processed meat proteins, which further upregulate pro-inflammatory cytokines and lipogenic enzymes, contributing to the pathogenesis of NAFLD (Ahmad2019Processed).

In gliomas, especially glioblastoma multiforme (GBM), GLRX expression is significantly elevated compared to normal brain tissue. This upregulation is linked to the malignant phenotype of gliomas and is associated with poorer survival outcomes. GLRX is also involved in immune evasion by glioma cells, as it is correlated with inhibitory immune checkpoints like PD-1 and PD-L1, suggesting a role in creating an immunosuppressive tumor microenvironment (Chang2020Redox).

In cardiovascular diseases, GLRX plays a role in lipid metabolism and redox homeostasis. Its deficiency can lead to hyperlipidemia and fatty liver, contributing to cardiovascular risk factors. Conversely, GLRX overexpression can mitigate vascular permeability and prevent apoptosis in endothelial cells, highlighting its potential as a therapeutic target (Matsui2020Redox; Burns2020Role).

## Interactions
GLRX, or glutaredoxin 1 (Grx1), is involved in various protein interactions that influence cellular processes. Grx1 interacts with the inhibitory κB kinase β (IKK-β) by reversing its S-glutathionylation, a modification that inhibits IKK-β activity. This interaction is crucial for the activation of the NF-κB pathway, as Grx1 catalyzes the deglutathionylation of a critical cysteine residue (Cys-179) in IKK-β, thereby restoring its function and allowing NF-κB activation (Reynaert2006Dynamic).

Grx1 also interacts with proteins involved in redox signaling, such as sirtuin-1 (SirT1). It reverses the S-glutathionylation of SirT1, which is significant in regulating lipid metabolism and cellular stress responses. This interaction prevents the inactivation of SirT1, thereby influencing downstream proteins like p53 (Matsui2020Redox).

Additionally, Grx1 is involved in the deglutathionylation and denitrosylation of proteins, affecting processes like apoptosis and inflammation. It interacts with proteins such as GAPDH and NF-κB, impacting their function and contributing to cellular redox homeostasis (Ogata2021Glutaredoxin:). These interactions highlight the role of Grx1 in modulating protein activity through redox mechanisms.


## References


[1. (Reynaert2006Dynamic) Niki L. Reynaert, Albert van der Vliet, Amy S. Guala, Toby McGovern, Milena Hristova, Cristen Pantano, Nicholas H. Heintz, John Heim, Ye-Shih Ho, Dwight E. Matthews, Emiel F. M. Wouters, and Yvonne M. W. Janssen-Heininger. Dynamic redox control of nf-κb through glutaredoxin-regulated s-glutathionylation of inhibitory κb kinase β. Proceedings of the National Academy of Sciences, 103(35):13086–13091, August 2006. URL: http://dx.doi.org/10.1073/pnas.0603290103, doi:10.1073/pnas.0603290103. This article has 367 citations.](https://doi.org/10.1073/pnas.0603290103)

[2. (Ogata2021Glutaredoxin:) Fernando T. Ogata, Vasco Branco, Filipa F. Vale, and Lucia Coppo. Glutaredoxin: discovery, redox defense and much more. Redox Biology, 43:101975, July 2021. URL: http://dx.doi.org/10.1016/j.redox.2021.101975, doi:10.1016/j.redox.2021.101975. This article has 79 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.redox.2021.101975)

[3. (Matsui2020Redox) Reiko Matsui, Beatriz Ferran, Albin Oh, Dominique Croteau, Di Shao, Jingyan Han, David Richard Pimentel, and Markus Michael Bachschmid. Redox regulationviaglutaredoxin-1 and proteins-glutathionylation. Antioxidants &amp; Redox Signaling, 32(10):677–700, April 2020. URL: http://dx.doi.org/10.1089/ars.2019.7963, doi:10.1089/ars.2019.7963. This article has 76 citations.](https://doi.org/10.1089/ars.2019.7963)

[4. (Ahmad2019Processed) Muhammad Ijaz Ahmad, Xiaoyou Zou, Muhammad Umair Ijaz, Muzahir Hussain, Congcong Liu, Xinglian Xu, Guanghong Zhou, and Chunbao Li. Processed meat protein promoted inflammation and hepatic lipogenesis by upregulating nrf2/keap1 signaling pathway in glrx-deficient mice. Journal of Agricultural and Food Chemistry, 67(32):8794–8809, July 2019. URL: http://dx.doi.org/10.1021/acs.jafc.9b03136, doi:10.1021/acs.jafc.9b03136. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/acs.jafc.9b03136)

[5. (Berndt2021Glutaredoxins) Carsten Berndt, Loïck Christ, Nicolas Rouhier, and Ulrich Mühlenhoff. Glutaredoxins with iron-sulphur clusters in eukaryotes - structure, function and impact on disease. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1862(1):148317, January 2021. URL: http://dx.doi.org/10.1016/j.bbabio.2020.148317, doi:10.1016/j.bbabio.2020.148317. This article has 20 citations.](https://doi.org/10.1016/j.bbabio.2020.148317)

[6. (Mieyal2008Molecular) John J. Mieyal, Molly M. Gallogly, Suparna Qanungo, Elizabeth A. Sabens, and Melissa D. Shelton. Molecular mechanisms and clinical implications of reversible proteins-glutathionylation. Antioxidants &amp; Redox Signaling, 10(11):1941–1988, November 2008. URL: http://dx.doi.org/10.1089/ars.2008.2089, doi:10.1089/ars.2008.2089. This article has 456 citations.](https://doi.org/10.1089/ars.2008.2089)

[7. (Sagemark2007Redox) Johan Sagemark, Tobias H. Elgán, Thomas R. Bürglin, Catrine Johansson, Arne Holmgren, and Kurt D. Berndt. Redox properties and evolution of human glutaredoxins. Proteins: Structure, Function, and Bioinformatics, 68(4):879–892, June 2007. URL: http://dx.doi.org/10.1002/prot.21416, doi:10.1002/prot.21416. This article has 44 citations.](https://doi.org/10.1002/prot.21416)

[8. (Chang2020Redox) Yuanhao Chang, Guanzhang Li, You Zhai, Lijie Huang, Yuemei Feng, Di Wang, Wei Zhang, and Huimin Hu. Redox regulator glrx is associated with tumor immunity in glioma. Frontiers in Immunology, November 2020. URL: http://dx.doi.org/10.3389/fimmu.2020.580934, doi:10.3389/fimmu.2020.580934. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2020.580934)

[9. (Burns2020Role) Mannix Burns, Syed Husain Mustafa Rizvi, Yuko Tsukahara, David R. Pimentel, Ivan Luptak, Naomi M. Hamburg, Reiko Matsui, and Markus M. Bachschmid. Role of glutaredoxin-1 and glutathionylation in cardiovascular diseases. International Journal of Molecular Sciences, 21(18):6803, September 2020. URL: http://dx.doi.org/10.3390/ijms21186803, doi:10.3390/ijms21186803. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21186803)